A bill representing the largest overhaul of state government in decades is again approaching passage. BMore >>
A bill representing the largest overhaul of state government in decades is again approaching passage. Both Gov. Nikki Haley and her chief Democratic opponent are working to get it to her desk in the legislative session's...More >>
Wednesday, May 15 2013 11:20 PM EDT2013-05-16 03:20:55 GMT
ANDREW MIGA Associated Press WASHINGTON (AP) - Republican Mark Sanford, the former South Carolina governor whose extramarital affair sank his political career in 2009, is returning to Congress to reclaimMore >>
Republican Mark Sanford, the former South Carolina governor whose extramarital affair sank his political career in 2009, is returning to Congress to reclaim his old House seat as he forges a comeback.More >>
Wednesday, May 15 2013 10:36 AM EDT2013-05-15 14:36:09 GMT
CHARLESTON, S.C. (AP) - Former South Carolina Gov. Mark Sanford is scheduled to be sworn in for a fourth term in the U.S. House. Sanford is set to take the oath of office on the House floor in WashingtonMore >>
Former South Carolina Gov. Mark Sanford is scheduled to be sworn in for a fourth term in the U.S. House.More >>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Ryan & Maniskas, LLP
WAYNE, Pa., March 19, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/pmti) is investigating potential claims against the board of directors of Palomar Medical Technologies Inc. ("Palomar Medical" or the "Company") (NASDAQ: PMTI) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Cynosure, Inc. in a deal valued at $294 million.
Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by the Company's board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of Palomar Medical. For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at email@example.com or visit: www.rmclasslaw.com/cases/pmti.
Under the terms of the proposed transaction, Palomar Medical's stockholders will receive $6.825 in cash and $6.825 in Cynosure, Inc. common stock for each share of Palomar common stock they own.
If you own shares of Palomar Medical and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/pmti. You may also email Mr. Maniskas at firstname.lastname@example.org. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.